“…Collagen matrix (CM) is routinely used as a biocompatible material for soft tissue augmentation. Xenogeneic CM achieved acceptable tissue volume and thickness increases, minimal pain in patients, and no evidence of infections compared to autogenous transplants based on several preclinical and clinical studies (Herford, Akin, Cicciu, Maiorana, & Boyne, ; Schmitt et al, ; Schmitt et al, ; Thoma et al, ; Thoma, Naenni, Benic, Hämmerle, & Jung, ). To improve the high shrinkage of natural noncross‐linked CM (ncl_CM), cross‐linked CM (cl_CM) was proposed, which could maintain a stable tissue volume because enzymatic degradation was controlled, resulting in slower degradation (Herford, Nguyen, Miller, Tandon, & Signorino, ; Huber, Zeltner, Hämmerle, Jung, & Thoma, ; Rothamel et al, ; Thoma et al, ).…”